Etripamil Nasal Spray in Patients With Paroxysmal Supraventricular Tachycardia

NCT04952610 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

130

Enrollment

OTHER

Sponsor class

Conditions

Paroxysmal Supraventricular Tachycardia

Interventions

DRUG: Etripamil NS 70 mg
DEVICE: Aptar Pharma Nasal Spray Bidose System

Sponsor

Milestone Pharmaceuticals Inc.